SAIMSARA Journal

Machine-Readable Science • ISSN 3054-3991

Flow Diverters for Aneurysm Treatment: Scoping Review with ☸️SAIMSARA.

Cardiac & Vascular Health icon

Cardiac & Vascular Health

Issue 1, Volume 1, 2026

DOI: 10.62487/saimsara0494831d

Editorial note
• Last update: 2026-05-30 12:33:00
What is this paper about
Flow diverters have reshaped aneurysm treatment, but their success depends heavily on anatomy, device behavior, and procedural strategy. The full read maps 252 references and 1439 original studies to separate strong indications from high-risk zones, giving a practical evidence overview for clinicians, researchers, and endovascular teams.
Human-verified editorial review Verified by World ID proof-of-human. This editorial layer was submitted from a SAIMSARA account verified as a unique human.


Abstract: To synthesize the structured extraction evidence on “flow diverter” studies, emphasizing clinical effectiveness, safety, mechanistic rationale, procedural determinants, device evolution, imaging follow-up, antiplatelet strategy, and research directions relevant to FD use. The review uses 252 references and builds its evidence map from 1439 original studies with 161646 total participants/sample observations (topic-deduplicated ΣN). Across this evidence map, flow diversion emerges as a mature but selection-sensitive reconstructive therapy whose benefit is conditional on matching aneurysm anatomy, device mechanics, and periprocedural management. The most consistent signal supports durable occlusion in large, giant, wide-neck, and internal carotid aneurysms, with randomized data showing 75.34% versus 24.53% complete occlusion favoring Tubridge over stent-assisted coiling and Surpass reaching 90.2% occlusion at 5 years, while middle cerebral bifurcation, fetal-type posterior communicating, branch-incorporated, and acutely ruptured lesions remain higher-risk indications. Deployment quality, apposition, sizing, and antiplatelet strategy repeatedly emerged as modifiable determinants of outcome rather than fixed device properties. The dominant uncertainty is comparative: head-to-head randomized trials in anatomically defined subgroups, paired with harmonized occlusion and complication endpoints, are the priority next step to convert this largely retrospective signal into actionable guidance.

Keywords: Flow diverter; Intracranial aneurysm; Endovascular treatment; Aneurysm occlusion; Pipeline embolization device; Tubridge flow diverter; Stent deployment; Parent artery; In-stent stenosis; Posterior circulation

Review Stats

Get access to the full paper

Unlock the full evidence map

Full paper access includes the complete human-readable review, figures, reference index, PDF export, and machine-readable Evidence JSON download.
Evidence JSON can also be purchased separately if you only need the LLM-ready object for agent, AI, or RAG workflows.
Institutional or library access? Sign in with your institution email to open all available SAIMSARA papers under your institution access arrangement.
Need a SAIMSARA review on your own topic? ☸️Request.

Reference Index (252)

Unlock the full paper to view the complete Reference Index.